Literature DB >> 29549409

Relative risk and population-attributable fraction of ICU death caused by susceptible and resistant Pseudomonas aeruginosa ventilator-associated pneumonia: a competing risks approach to investigate the OUTCOMEREA database.

Maja K von Cube1, Jean-Francois Timsit2,3, Harriet Sommer4, Michael Darmon5,6, Carole Schwebel7, Sebastien Bailly8,9, Bertrand Souweine10, Martin Wolkewitz4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29549409     DOI： 10.1007/s00134-018-5109-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

Review 1.  Ventilator associated pneumonia.

Authors:  John D Hunter
Journal:  BMJ       Date:  2012-05-29

2.  Multistate Modeling to Analyze Nosocomial Infection Data: An Introduction and Demonstration.

Authors:  Martin Wolkewitz; Maja von Cube; Martin Schumacher
Journal:  Infect Control Hosp Epidemiol       Date:  2017-06-21       Impact factor: 3.254

3.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

4.  Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies.

Authors:  Wilhelmina G Melsen; Maroeska M Rovers; Rolf H H Groenwold; Dennis C J J Bergmans; Christophe Camus; Torsten T Bauer; Ernst W Hanisch; Bengt Klarin; Mirelle Koeman; Wolfgang A Krueger; Jean-Claude Lacherade; Leonardo Lorente; Ziad A Memish; Lee E Morrow; Giuseppe Nardi; Christianne A van Nieuwenhoven; Grant E O'Keefe; George Nakos; Frank A Scannapieco; Philippe Seguin; Thomas Staudinger; Arzu Topeli; Miquel Ferrer; Marc J M Bonten
Journal:  Lancet Infect Dis       Date:  2013-04-25       Impact factor: 25.071

5.  Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.

Authors:  Laia Fernández-Barat; Miquel Ferrer; Francesca De Rosa; Albert Gabarrús; Mariano Esperatti; Silvia Terraneo; Mariano Rinaudo; Gianluigi Li Bassi; Antoni Torres
Journal:  J Infect       Date:  2016-11-16       Impact factor: 6.072

6.  Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.

Authors:  Benjamin Planquette; Jean-Francois Timsit; Benoit Y Misset; Carole Schwebel; Elie Azoulay; Christophe Adrie; Aurélien Vesin; Samir Jamali; Jean-Ralph Zahar; Bernard Allaouchiche; Bertrand Souweine; Michael Darmon; Anne-Sylvie Dumenil; Dany Goldgran-Toledano; Bruno H Mourvillier; Jean-Pierre Bédos
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405
  6 in total
  1 in total

1.  Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP.

Authors:  Wei Gao; Julie Passarell; Yogesh T Patel; Zufei Zhang; Gina Lin; Jill Fiedler-Kelly; Christopher J Bruno; Elizabeth G Rhee; Carisa S De Anda; Hwa-Ping Feng
Journal:  Antimicrob Agents Chemother       Date:  2022-04-26       Impact factor: 5.938
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.